Key result
Different regional fat depots, particularly visceral adipose tissue and liver fat, are associated with an increased risk of cognitive impairment, dementia, and deleterious brain changes.
Why the study?
BMI measures global adiposity inconsistently and fails to represent regional fat distribution, which may contribute differently to cognitive decline and Alzheimer disease-related brain changes.
Does regional adiposity increase the risk of cognitive impairment and dementia-related brain changes in adults?
Systematic Review (n=44,327)
Does regional adiposity increase the risk of cognitive impairment and dementia-related brain changes in adults?
Regional adiposity, particularly visceral and hepatic fat, is associated with cognitive decline and dementia-related brain changes, suggesting fat distribution is a more specific risk marker than global BMI.
May inform risk stratification beyond BMI; leaves open whether targeting visceral or liver fat alters cognitive outcomes.
Background: Adiposity has been previously associated with cognitive impairment and Alzheimer's disease and related disorders (ADRD). Body mass index (BMI) is the most common measure of global adiposity, but inconsistent results were found since it is a global measurement. BMI does not represent regional fat distribution which differs between sexes, race, and age. Regional fat distribution may contribute differently to cognitive decline and Alzheimer's disease (AD)-related brain changes. Fat-specific targeted therapies could lead to personalized improvement of cognition. The goal of this systematic review is to explore whether regional fat depots, rather than central obesity, should be used to understand the mechanism underlying the association between adiposity and brain. Methods: This systematic review included 33 studies in the English language, conducted in humans aged 18 years and over with assessment of regional adiposity, cognitive function, dementia, and brain measures. We included only studies that have assessed regional adiposity using imaging technics and excluded studies that were review articles, abstract only or letters to editor. Studies on children and adolescents, animal studies, and studies of patients with gastrointestinal diseases were excluded. PubMed, PsychInfo and web of science were used as electronic databases for literature search until November 2022. Results: Based on the currently available literature, the findings suggest that different regional fat depots are likely associated with increased risk of cognitive impairment, brain changes and dementia, especially AD. However, different regional fat depots can have different cognitive outcomes and affect the brain differently. Visceral adipose tissue (VAT) was the most studied regional fat, along with liver fat through non-alcoholic fatty liver disease (NAFLD). Pancreatic fat was the least studied regional fat. Conclusion: Regional adiposity, which is modifiable, may explain discrepancies in associations of global adiposity, brain, and cognition. Specific regional fat depots lead to abnormal secretion of adipose factors which in turn may penetrate the blood brain barrier leading to brain damage and to cognitive decline.
No takes yet. Share an insight, caveat, or question.
Boccara et al. (2023) conducted a systematic review in Cognitive impairment and dementia-related brain changes (n=44,327). Regional adiposity (e.g., visceral adipose tissue, hepatic fat) vs. Lower regional adiposity was evaluated on Cognitive impairment, brain changes, and dementia risk. Different regional fat depots, particularly visceral adipose tissue and liver fat, are associated with an increased risk of cognitive impairment, dementia, and deleterious brain changes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: